Conformation of aspartate aminotransferase isozymes folding under different conditions probed by limited proteolysis.
The partially homologous mitochondrial (mAAT) and cytosolic (cAAT) aspartate aminotransferase have nearly identical three-dimensional structures but differ in their folding rates in cell-free extracts and in their affinity for binding to molecular chaperones. In its native state, each isozyme is protease-resistant. Using limited proteolysis as an index of their conformational states, we have characterized these proteins (a) during the early stages of spontaneous refolding; (b) as species trapped in stable complexes with the chaperonin GroEL; or (c) as newly translated polypeptides in cell-free extracts. Treatment of the refolding proteins with trypsin generates reproducible patterns of large proteolytic fragments that are consistent with the formation of defined folding domains soon after initiating refolding. Binding to GroEL affords considerable protection to both isozymes against proteolysis. The tryptic fragments are similar in size for both isozymes, suggesting a common distribution of compact and flexible regions in their folding intermediates. cAAT synthesized in cell-free extracts becomes protease-resistant almost instantaneously, whereas trypsin digestion of the mAAT translation product produces a pattern of fragments qualitatively akin to that observed with the protein refolding in buffer. Analysis of the large tryptic peptides obtained with the GroEL-bound proteins reveals that the cleavage sites are located in analogous regions of the N-terminal portion of each isozyme. These results suggest that (a) binding to GroEL does not cause unfolding of AAT, at least to an extent detectable by proteolysis; (b) the compact folding domains identified in AAT bound to GroEL (or in mAAT fresh translation product) are already present at the early stages of refolding of the proteins in buffer alone; and (c) the two isozymes seem to bind in a similar fashion to GroEL, with the more compact C-terminal portion completely protected and the more flexible N-terminal first 100 residues still partially accessible to proteolysis.
Mattingly
J R
JR
Division of Molecular Biology and Biochemistry, School of Biological Sciences, University of Missouri, Kansas City, Missouri 64110-2499, USA.
Torella
C
C
Iriarte
A
A
Martinez-Carrion
M
M
D001219:Aspartate Aminotransferases / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D018834:Chaperonin 60 / Q000378:metabolism; D003600:Cytosol / Q000201:enzymology; D007527:Isoenzymes / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D008928:Mitochondria / Q000201:enzymology; D008956:Models, Chemical; D008958:Models, Molecular; D010446:Peptide Fragments; D014176:Protein Biosynthesis; D011487:Protein Conformation; D017510:Protein Folding; D014357:Trypsin / Q000494:pharmacology
D018834:Chaperonin 60; D007527:Isoenzymes; D010446:Peptide Fragments; D001219:Aspartate Aminotransferases; D014357:Trypsin